As of 2025-11-24, the Intrinsic Value of Aldeyra Therapeutics Inc (ALDX) is -3.61 USD. This ALDX valuation is based on the model Peter Lynch Fair Value. With the current market price of 4.96 USD, the upside of Aldeyra Therapeutics Inc is -172.69%.
Based on its market price of 4.96 USD and our intrinsic valuation, Aldeyra Therapeutics Inc (ALDX) is overvalued by 172.69%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -3.61 - -3.61 | -3.61 | -172.69% |
| P/E | (5.49) - (10.40) | (7.64) | -254.1% |
| DDM - Stable | (5.43) - (16.48) | (10.96) | -320.9% |
| DDM - Multi | (6.48) - (15.51) | (9.17) | -284.8% |
| Market Cap (mil) | 297.10 |
| Beta | 3.16 |
| Outstanding shares (mil) | 59.90 |
| Enterprise Value (mil) | 252.96 |
| Market risk premium | 4.60% |
| Cost of Equity | 10.62% |
| Cost of Debt | 5.00% |
| WACC | 10.28% |